The amyloid β-protein (Aβ) 42 plays a pivotal role in Alzheimer disease (AD). We have previously reported that intracellular Aβ42 is associated with neuronal apoptosis (Chui et al, 1999, Chui et al, 2001). AD may be caused by toxic aggregates formed from Aβpeptides. By using Thioflavin T, a dye t...
Alzheimer's disease (AD) is the major and common disease usually for aged people to show progressive...
This paper will be a review of current and ongoing literature surrounding how the aggregation of amy...
A key feature of Alzheimer disease (AD) is the pathologic self-association of the amyloid-β (Aβ) pep...
Alzheimer's disease is a devastating disorder that is estimated to affect more than 25 million peopl...
Proposed treatments of Alzheimer\u27s disease (AD) are most likely to succeed if they are based on a...
Alzheimer's Disease (AD), the most common age-related neurodegenerative disorder, is characterized b...
International audienceAfter three decades of false hopes and failures, a pipeline of therapeutic dru...
Amyloid-β (Aβ) is a dynamic peptide of Alzheimer’s disease (AD) which accelerates the disease progre...
One of the hallmarks of Alzheimer’s disease (AD) is the formation of senile plaques in the brain, wh...
Alzheimer’s disease (AD) is chronic neurodegenerative dementia representing the most common cause of...
Alzheimer’s disease (AD) is a fatal neurodegenerative disorder, and the most common cause of dementi...
Alzheimer’s disease (AD) is an incurable, neurodegenerative and terminal disease that is generally p...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that leads to memory deficits a...
Several lines of evidence indicate that amyloid β (Aβ), particularly Aβ oligomers (AβOs), plays a ca...
Accumulating evidence has shown a strong relationship between Alzheimer’s disease (AD), cerebral amy...
Alzheimer's disease (AD) is the major and common disease usually for aged people to show progressive...
This paper will be a review of current and ongoing literature surrounding how the aggregation of amy...
A key feature of Alzheimer disease (AD) is the pathologic self-association of the amyloid-β (Aβ) pep...
Alzheimer's disease is a devastating disorder that is estimated to affect more than 25 million peopl...
Proposed treatments of Alzheimer\u27s disease (AD) are most likely to succeed if they are based on a...
Alzheimer's Disease (AD), the most common age-related neurodegenerative disorder, is characterized b...
International audienceAfter three decades of false hopes and failures, a pipeline of therapeutic dru...
Amyloid-β (Aβ) is a dynamic peptide of Alzheimer’s disease (AD) which accelerates the disease progre...
One of the hallmarks of Alzheimer’s disease (AD) is the formation of senile plaques in the brain, wh...
Alzheimer’s disease (AD) is chronic neurodegenerative dementia representing the most common cause of...
Alzheimer’s disease (AD) is a fatal neurodegenerative disorder, and the most common cause of dementi...
Alzheimer’s disease (AD) is an incurable, neurodegenerative and terminal disease that is generally p...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that leads to memory deficits a...
Several lines of evidence indicate that amyloid β (Aβ), particularly Aβ oligomers (AβOs), plays a ca...
Accumulating evidence has shown a strong relationship between Alzheimer’s disease (AD), cerebral amy...
Alzheimer's disease (AD) is the major and common disease usually for aged people to show progressive...
This paper will be a review of current and ongoing literature surrounding how the aggregation of amy...
A key feature of Alzheimer disease (AD) is the pathologic self-association of the amyloid-β (Aβ) pep...